News + Filings Holdings
|
Ghost Tree Capital, LLC
|
|
Changes: All | New | Increased | Decreased | Sold Out |
Portfolio as of: |
Name | Ticker | Class | Shares | Change | Value | Change | % Port | % OS | Hist | Date |
MoonLake Immunotherapeutics
| MLTX | Common | 330,000 | 135,000 | 16,830,000,000 | 12,659,000,000 | 5.56 | 0.63 |
Hist
| 06/30/2023 |
Akero Therapeutics, Inc.
| AKRO | Common | 360,000 | 85,000 | 16,808,400,000 | 6,286,400,000 | 5.55 | 0.72 |
Hist
| 06/30/2023 |
Vaxcyte, Inc.
| PCVX | Common | 280,000 | 55,000 | 13,983,200,000 | 5,550,200,000 | 4.62 | 0.30 |
Hist
| 06/30/2023 |
Paragon Airheater Technologies, Inc.
| APLS | COM | 180,000 | 15,380 | 16,398,000,000 | 5,540,000,000 | 5.41 | |
Hist
| 06/30/2023 |
MADRIGAL PHARMACEUTICALS, INC.
| MDGL | Common | 55,000 | 25,000 | 12,705,000,000 | 5,437,000,000 | 4.19 | 0.30 |
Hist
| 06/30/2023 |
Revance Therapeutics, Inc.
| RVNC | Common | 525,000 | 275,000 | 13,287,750,000 | 5,234,750,000 | 4.39 | 0.62 |
Hist
| 06/30/2023 |
REATA PHARMACEUTICALS INC
| RETA | Common | 85,000 | 15,000 | 8,666,600,000 | 2,302,600,000 | 2.86 | |
Hist
| 06/30/2023 |
ALPINE IMMUNE SCIENCES, INC.
| ALPN | Common | 347,432 | 147,432 | 3,571,601,000 | 2,027,601,000 | 1.18 | 0.72 |
Hist
| 06/30/2023 |
Mirati Therapeutics, Inc.
| MRTX | COM | 200,000 | 60,000 | 7,226,000,000 | 2,021,000,000 | 2.39 | 0.34 |
Hist
| 06/30/2023 |
Tarsus Pharmaceuticals, Inc.
| TARS | Common | 150,000 | 70,000 | 2,710,500,000 | 1,704,500,000 | 0.89 | 0.56 |
Hist
| 06/30/2023 |
Sarepta Therapeutics, Inc.
| SRPT | Common | 85,000 | 25,000 | 9,734,200,000 | 1,464,200,000 | 3.21 | 0.10 |
Hist
| 06/30/2023 |
Viridian Therapeutics, Inc.\DE
| VRDN | COM | 240,000 | 65,000 | 5,709,600,000 | 1,257,600,000 | 1.88 | 0.56 |
Hist
| 06/30/2023 |
Cogent Biosciences, Inc.
| COGT | Common | 575,000 | 25,000 | 6,808,000,000 | 873,000,000 | 2.25 | 0.81 |
Hist
| 06/30/2023 |
Aadi Bioscience, Inc.
| AADI | Common | 250,000 | 100,000 | 1,710,000,000 | 624,000,000 | 0.56 | 1.02 |
Hist
| 06/30/2023 |
Fusion Pharmaceuticals Inc.
| FUSN | Common | 412,699 | 62,699 | 1,927,304,000 | 607,304,000 | 0.64 | 0.65 |
Hist
| 06/30/2023 |
Viking Therapeutics, Inc.
| VKTX | COM | 650,000 | 50,000 | 10,536,500,000 | 546,500,000 | 3.48 | |
Hist
| 06/30/2023 |
Syndax Pharmaceuticals Inc
| SNDX | Common | 350,000 | 25,000 | 7,325,500,000 | 461,500,000 | 2.42 | 0.51 |
Hist
| 06/30/2023 |
Biomea Fusion, Inc.
| BMEA | Common | 190,000 | 70,000 | 4,170,500,000 | 449,500,000 | 1.38 | |
Hist
| 06/30/2023 |
BridgeBio Pharma, Inc.
| BBIO | Common | 42,000 | 17,000 | 722,400,000 | 307,400,000 | 0.24 | 0.03 |
Hist
| 06/30/2023 |
Vanda Pharmaceuticals Inc.
| VNDA | COM | 31,000 | 18,500 | 204,290,000 | 119,290,000 | 0.07 | |
Hist
| 06/30/2023 |
FIBROGEN INC
| FGEN | COM | 36,500 | 10,000 | 98,550,000 | -395,450,000 | 0.03 | 0.04 |
Hist
| 06/30/2023 |
Aerovate Therapeutics, Inc.
| AVTE | Common | 201,197 | 1,197 | 3,450,529,000 | -583,471,000 | 1.14 | |
Hist
| 06/30/2023 |
Rain Oncology Inc.
| RAIN | Common | 325,000 | 75,000 | 390,000,000 | -1,795,000,000 | 0.13 | 0.89 |
Hist
| 06/30/2023 |
Amylyx Pharmaceuticals, Inc.
| AMLX | Common | 550,000 | 75,000 | 11,863,500,000 | -2,073,500,000 | 3.92 | 0.82 |
Hist
| 06/30/2023 |
|
|
|
|